Recent research conducted by the USC Schaeffer Center has illuminated the significant impact a modest financial incentive can have on improving enrollment of low-income individuals in Alzheimer’s disease clinical research. The findings were published in JAMA Health Forum on August 22, 2025, highlighting the necessity of innovative recruitment strategies for clinical trials aimed at enhancing representation from marginalized communities.

Enhancing Clinical Trial Participation

Clinical trials are essential for advancing research in Alzheimer's disease; however, they often struggle to recruit a diverse participant pool. Traditional recruitment methods may inadvertently exclude underrepresented groups, thereby limiting the generalizability of research findings. The study's authors identified an opportunity to assess whether offering a small financial incentive, in this case, a gift card, could enhance participation rates among low-income demographics.

The research involved nearly 50,000 adults aged 50 and older, all of whom were engaged through an integrated county health system servicing predominantly Medicaid enrollees. Individuals were randomly assigned to one of three groups:

  • Active Control Group: Received a simple invitation to register.
  • Gift Card Group: Offered a $25 Amazon gift card upon enrollment.
  • Prize Drawing Group: Entered into a drawing for a $2,500 Amazon gift card, with a 1-in-100 chance of winning.

Key Findings

The results were telling. The introduction of the $25 gift card incentive led to an almost 40% increase in enrollment compared to the control group that received no financial incentive. Interestingly, while the prize drawing offered the allure of a larger potential reward, it failed to produce a statistically significant increase in enrollment. This suggests that the simplicity and immediate gratification of a smaller incentive may be more effective for this demographic.

Group Type Incentive Offered Enrollment Increase
Active Control None Baseline
Gift Card Group $25 Amazon gift card ~40% increase
Prize Drawing Group Entry for $2,500 drawing No significant effect

Cost-Effectiveness Evaluation

Despite the initial allure of using financial incentives to boost enrollment, the study also suggested that the message-only approach was significantly more cost-effective. Engaging in outreach efforts amongst underrepresented communities proved to provide a more sustainable and effective recruitment strategy.

“This study underlines the importance of tailoring recruitment strategies to diverse populations and the potential impact of small incentives in clinical research.” – Mireille Jacobson, Co-author and Professor at USC Leonard Davis School of Gerontology

Future Implications

The implications of these findings extend beyond just recruiting for clinical trials; they also raise broader questions regarding ethics and the use of financial incentives in medical research. It is vital that future studies consider both the ethical dimensions and the practical outcomes of incentivizing participation.

As the healthcare landscape continues to evolve, there is a pressing need for equitable representation in clinical trials, particularly for conditions like Alzheimer’s disease that disproportionately affect underrepresented populations. This research is a significant step towards understanding and overcoming the barriers that have historically limited participation in clinical studies.

For further reading: More details can be found in the article "Financial Incentives to Increase Diversity of Older Participants in a Memory Concerns Registry" published in JAMA Health Forum (2025). Click here for the original study.

References

[1] Jacobson, M., & Molina-Henry, D. (2025). Financial Incentives to Increase Diversity of Older Participants in a Memory Concerns Registry. JAMA Health Forum.

[2] USC Schaeffer Center for Health Policy and Economics.

[3] Alzheimer’s Therapeutic Research Institute (ATRI).